Sandoz and Pear Therapeutics announce launch of reSET® for treatment of patients with Substance Use Disorder

Sandoz, a Novartis division, and Pear Therapeutics, Inc.,  recently announced the commercial launch of reSET® for patients with Substance Use Disorder (SUD). reSET, the first and only FDA-authorized prescription digital therapeutic, is immediately available.